Trieu Vuong bought OTLC

June 23, 2026 · Form 4 insider transaction

Trieu Vuong bought 75,000 shares of Oncotelic Therapeutics, Inc. at $0.04 per share, a transaction worth $3.4K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
75,000
Price
$0.04
Total value
$3.4K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJune 23, 2026
Filing dateJune 24, 2026
Shares owned after93,769,319
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

On June 22, 2026, Dr. Vuong Trieu purchased 65,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.045. Further, on June 23, 2026, Dr. Vuong Trieu purchased 75,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.045. Further, on June 24, 2026, Dr. Vuong Trieu purchased 115,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.045.

View the original Form 4 on SEC EDGAR